Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
- Status
- WITHDRAWN
- Phase
- N/A
Deep Liver Phenotyping and Immunology Study
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
- Status
- UNKNOWN
- Phase
- N/A
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Status
- RECRUITING
- Phase
- N/A
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
- Status
- RECRUITING
- Phase
- N/A
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- NA
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1